Woodline reports 7.0% stake (3.65M shares) in OKYO
OKYO Pharma LTD disclosure: Woodline Partners LP reports beneficial ownership of 3,652,190 shares of Ordinary Shares, representing 7.0% of the class based on an aggregate of 52,479,257 Ordinary Shares described in the filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
OKYO Pharma LTD disclosure: Woodline Partners LP reports beneficial ownership of 3,652,190 shares of Ordinary Shares, representing 7.0% of the class based on an aggregate of 52,479,257 Ordinary Shares described in the filing. The shares are held on behalf of the Woodline Fund.
The filing states Woodline has sole voting and sole dispositive power over the 3,652,190 shares. The disclosure is formatted as a Schedule 13G beneficial-ownership statement and is signed by the reporting person’s GC and CCO.
Insights
Woodline reports a 7.0% stake (3,652,190 shares) in OKYO Pharma.
The filing shows Woodline Partners LP holds 3,652,190 shares with sole voting and dispositive power, disclosed on behalf of the Woodline Fund. The percent is calculated using an aggregate share base of 52,479,257.
This Schedule 13G is a passive beneficial-ownership disclosure framework; subsequent Form 13D or Form 4 filings would change the record if activism or transactions occur. Future SEC filings will show any changes in holdings.
Disclosure aligns with passive-investor Schedule 13G conventions and cites sole voting/dispositive powers.
The statement identifies the reporting person, address, CUSIP G6724L116, and that the holdings are reported on behalf of the Woodline Fund. It cites the share base used to compute 7.0%.
Signatory is the Reporting Person’s GC/CCO with a signature date of 05/15/2026. Changes in ownership or intent would require amended filings under SEC rules.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
sole dispositive power regulatory
CUSIP financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Woodline Partners report in OKYO (OKYO)?
How was the 7.0% ownership percentage calculated?
Does this Schedule 13G indicate activism or trading intent by Woodline?
AI-generated analysis. How Rhea-AI works. Not financial advice.